AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Ioversol Equivalent To
9 registrations across 1 African market— 6 active
Markets with Ioversol Equivalent To
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| OPTIRAY 300 - 30 ml | 🇿🇦South Africa | Guerbet South Africa (Pty) Ltd | suspended | Jan 2024 |
| OPTIRAY 240 - 50 ml | 🇿🇦South Africa | Guerbet South Africa (Pty) Ltd | suspended | Jan 2024 |
| OPTIRAY 240 - 100 ml | 🇿🇦South Africa | Guerbet South Africa (Pty) Ltd | suspended | Jan 2024 |
| OPTIRAY 300 - 100 ml | 🇿🇦South Africa | Guerbet South Africa (Pty) Ltd | active | Jan 1900 |
| OPTIRAY 320 | 🇿🇦South Africa | Guerbet South Africa (Pty) Ltd | active | Jan 1900 |
| OPTIRAY 320 - 50 ml | 🇿🇦South Africa | Guerbet South Africa (Pty) Ltd | active | Jan 1900 |
| OPTIRAY 350 - 100 ml | 🇿🇦South Africa | Guerbet South Africa (Pty) Ltd | active | Jan 1900 |
| OPTIRAY 300 | 🇿🇦South Africa | Guerbet South Africa (Pty) Ltd | active | Jan 1900 |
| OPTIRAY 350 | 🇿🇦South Africa | Guerbet South Africa (Pty) Ltd | active | Jan 1900 |
Ioversol Equivalent To in Africa — Regulatory Overview
Ioversol Equivalent To is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 6 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.